| pubmed-article:19071018 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19071018 | lifeskim:mentions | umls-concept:C0140080 | lld:lifeskim |
| pubmed-article:19071018 | lifeskim:mentions | umls-concept:C1367731 | lld:lifeskim |
| pubmed-article:19071018 | lifeskim:mentions | umls-concept:C1150587 | lld:lifeskim |
| pubmed-article:19071018 | lifeskim:mentions | umls-concept:C1705632 | lld:lifeskim |
| pubmed-article:19071018 | lifeskim:mentions | umls-concept:C1268567 | lld:lifeskim |
| pubmed-article:19071018 | lifeskim:mentions | umls-concept:C2757011 | lld:lifeskim |
| pubmed-article:19071018 | lifeskim:mentions | umls-concept:C2698650 | lld:lifeskim |
| pubmed-article:19071018 | lifeskim:mentions | umls-concept:C0034284 | lld:lifeskim |
| pubmed-article:19071018 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19071018 | pubmed:dateCreated | 2008-12-26 | lld:pubmed |
| pubmed-article:19071018 | pubmed:abstractText | The SAR of C5' functional groups with terminal basic amines at the C6 aniline of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines is reported. Examples demonstrate potent inhibition of IGF-1R with 1000-fold selectivity over JNK1 and 3 in enzymatic assays. | lld:pubmed |
| pubmed-article:19071018 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19071018 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19071018 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19071018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19071018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19071018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19071018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19071018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19071018 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19071018 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19071018 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19071018 | pubmed:issn | 1464-3405 | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:VyasSS | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:KumarRakeshR | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:DeandaFelixF | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:LeiHuangshuH | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:WilsonJoseph... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:SabbatiniPete... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:ShotwellJ... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:HassellAnne... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:SmithJeffery... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:AtkinsCharity... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:MookRobert... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:ShewchukLisa... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:PatnaikSamarj... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:LeesnitzerM... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:RedmanAnikó... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:StevensKirk... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:ChamberlainSt... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:RowandJason... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:MoorthyGanesh... | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:GroyArthurA | lld:pubmed |
| pubmed-article:19071018 | pubmed:author | pubmed-author:GerdingRosean... | lld:pubmed |
| pubmed-article:19071018 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19071018 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:19071018 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:19071018 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19071018 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19071018 | pubmed:pagination | 360-4 | lld:pubmed |
| pubmed-article:19071018 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:19071018 | pubmed:meshHeading | pubmed-meshheading:19071018... | lld:pubmed |
| pubmed-article:19071018 | pubmed:meshHeading | pubmed-meshheading:19071018... | lld:pubmed |
| pubmed-article:19071018 | pubmed:meshHeading | pubmed-meshheading:19071018... | lld:pubmed |
| pubmed-article:19071018 | pubmed:meshHeading | pubmed-meshheading:19071018... | lld:pubmed |
| pubmed-article:19071018 | pubmed:meshHeading | pubmed-meshheading:19071018... | lld:pubmed |
| pubmed-article:19071018 | pubmed:meshHeading | pubmed-meshheading:19071018... | lld:pubmed |
| pubmed-article:19071018 | pubmed:meshHeading | pubmed-meshheading:19071018... | lld:pubmed |
| pubmed-article:19071018 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19071018 | pubmed:articleTitle | Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity. | lld:pubmed |
| pubmed-article:19071018 | pubmed:affiliation | GlaxoSmithKline, Oncology R&D, 5 Moore Drive, Research Triangle Park, NC 27709, USA. | lld:pubmed |
| pubmed-article:19071018 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19071018 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19071018 | lld:pubmed |
